Last reviewed 2026-06-01 · How we verify

Clomidazole (CHLORMIDAZOLE)

Phase 2 active Small molecule ✓ Verified Jun 2026 Quality 24/100

Clomidazole (generic name: CHLORMIDAZOLE) is a chlormidazole drug. It is currently in Phase 2 development.

Clomidazole works by disrupting the growth and reproduction of microorganisms, such as bacteria and fungi.

Clomifene, also known as Clomid, is a small molecule. It is also known by other names, including Clormidazol and Chlorimidazole.

Likelihood of approval

17.3% vs 15.3% industry baseline

If approved by FDA: likely 2031–2034

Steps remaining: Phase 3 → NDA/BLA submission

Confidence: Medium

Why this estimate

Baseline phase 2 → approval rate +15.3pp
Industry-wide phase 2 drugs reach approval ~15.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Anti-infectives pathway favourability +2.0pp
Microbiological endpoints + non-inferiority designs raise approval rates above baseline.

Predicted approval windows by jurisdiction (conditional on FDA approval)

Regulator	Country	Likely year	Lag vs FDA
FDA	US	2031–2034	—
EMA	EU	2032–2035	+0.7 yr
MHRA	GB	2032–2035	+0.7 yr
Health Canada	CA	2032–2036	+0.9 yr
TGA	AU	2032–2036	+1.2 yr
PMDA	JP	2032–2036	+1.5 yr
NMPA	CN	2033–2037	+2.3 yr
MFDS	KR	2032–2036	+1.4 yr
CDSCO	IN	2032–2037	+1.8 yr
ANVISA	BR	2033–2037	+2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic name	CHLORMIDAZOLE
Drug class	chlormidazole
Modality	Small molecule
Therapeutic area	Infectious Disease
Phase	Phase 2

Mechanism of action

Imagine your body as a garden, and microorganisms as weeds. Clomidazole is like a weed killer that prevents the weeds from growing and spreading, helping to keep your body healthy and free from infection.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Clomidazole CI brief — competitive landscape report
Clomidazole updates RSS · CI watch RSS

Frequently asked questions about Clomidazole

What is Clomidazole?

Clomidazole (CHLORMIDAZOLE) is a chlormidazole drug.

How does Clomidazole work?

Clomidazole works by disrupting the growth and reproduction of microorganisms, such as bacteria and fungi.

What is the generic name of Clomidazole?

CHLORMIDAZOLE is the generic (nonproprietary) name of Clomidazole.

What drug class is Clomidazole in?

Clomidazole belongs to the chlormidazole class. See all chlormidazole drugs at /class/chlormidazole.

What development phase is Clomidazole in?

Clomidazole is in Phase 2.

Drug class: All chlormidazole drugs
Therapeutic area: All drugs in Infectious Disease

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing